Showing results (311-320 of 322) with videos related to

Sort By:
Pageof 33
The Journal of Clinical Investigation|March 22, 2019
B cell maturation antigen-specific CAR T cells are clinically active in multiple myelomaAdam D Cohen, Alfred L Garfall, Edward A Stadtmauer, et al.
Annals of Neurology|April 13, 2026
Relapses, Comorbidities, and Predictors of Outcome in Anti-GABAA Receptor EncephalitisClaudia Papi, Chiara Milano, Laura Marmolejo, et al.
Annals of Clinical and Translational Neurology|December 11, 2014
High prevalence of NMDA receptor IgA/IgM antibodies in different dementia typesSarah Doss, Klaus-Peter Wandinger, Bradley T Hyman, et al.
Brain : a Journal of Neurology|July 12, 2025
Brain atrophy patterns in anti-IgLON5 diseaseSelina M Yogeshwar, Frederik Bartels, Thomas Grüter, et al.
Brain : a Journal of Neurology|March 1, 2024
HLA-DQB1*05 subtypes and not DRB1*10:01 mediates risk in anti-IgLON5 diseaseSelina M Yogeshwar, Sergio Muñiz-Castrillo, Lidia Sabater, et al.
Neurology|August 27, 2024
Investigating the 2023 MOGAD Criteria in Children and Adults With MOG-Antibody Positivity Within and Outside AttacksElianet Fonseca, Gemma Olivé-Cirera, Eugenia Martinez-Hernandez, et al.
The Lancet Regional Health. Europe|January 5, 2026
Development and validation of the NEOS2 score for prediction of long-term outcomes and improvement after first-line immunotherapy in patients with anti-NMDAR encephalitis: an international cohort studyJuliette Brenner, Anna E M Bastiaansen, Mar Guasp, et al.
Acta Neuropathologica|October 14, 2024
Neuropathological spectrum of anti-IgLON5 disease and stages of brainstem tau pathology: updated neuropathological research criteria of the disease-related tauopathyEllen Gelpi, Raphael Reinecke, Carles Gaig, et al.
Blood Cancer Discovery|November 22, 2022
Anti-BCMA/CD19 CAR T Cells with Early Immunomodulatory Maintenance for Multiple Myeloma Responding to Initial or Later-Line TherapyAlfred L Garfall, Adam D Cohen, Sandra P Susanibar-Adaniya, et al.
Neurology|August 12, 2021
Frequency and Characterization of Movement Disorders in Anti-IgLON5 DiseaseCarles Gaig, Yaroslau Compta, Anna Heidbreder, et al.
Pageof 33